Detection and quantification of synthetic drugs in herbal slimming formula

European Journal of Scientific Research

Volumn 34, Issue 3, 2009, Pages 348-357

  Kanan, Sofian ^a   Abu Yousef, Imad A ^a   Gunasekar, Conjeevaram ^a   Abdo, Naser ^a   Narasimhan, Srinivasan ^b  

^a AMERICAN UNIVERSITY OF SHARJAH   (United Arab Emirates)

^b Asthagiri Herbal Research Foundation   (India)

Author keywords

Herba; HPLC; Limit of quantification; Rimonabant; Sibutramine; Slimming drugs

Indexed keywords

EID: 70049112129     PISSN: 1450216X     EISSN: 1450202X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Binkley K, Knowles SR. 2002. Am. J. Psychiatry, Sibutramine and panic attacks. 159:1793-1794.
2. Bodeker G, Kronenberg F. 2002. Am. J. Publ Health, Public health agenda for traditional, complementary and alternative medicine. 92: 1582-91.
3. Cordeiro Q, Vallada H. 2002. Int. J. Neuropsychopharmacol, Sibutramine-induced mania episode in bipolar patient. 5: 283-284.
4. Deadwyler SA, Goonawardena AV, Hampson RE. 2007. Behavioural Pharmacology, Short-term memory is modulated by the spontaneous release of endocannabinoids: evidence from hippocampal population codes. 18 (5-6):571-580.
5. Fang Deng J. 2002. Toxicology Volumes, Clinical and laboratory investigations in herbal poisonings. 181-182: 571-576.
6. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. 2004. J. Clin. Psychopharmacology, Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. 24: 24-29.
7. FDA Medical Bulletin. U. S. Food and Drug Administration. 1994. Adverse Events with Ephedra and Other Botanical Dietary Supplements.
8. Herbal Safety News, published by the Medicines and Healthcare products Regulatory Agency. 2004. The Pharmaceutical Journal, Shubao liver damage risk. 273 (7310): 140.
9. Huestis MA, Gorelick DA, Heishman SJ, et al., 2001. Arch. Gen. Psychiatry, "Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716". 58 (4): 322-328.
10. Jung J, Hermanns CM, Weinmann W. 2006. Forensic. Sci. Int, Anorectic Sibutramine detected in a Chinese herbal drug for weight loss. 161: 221-222.
11. Kim AH, Kerchner GA, Choi DW. 2002. Springer, New York, Blocking Excitotoxicity, Chapter 1 in CNS Neuroproteciton. F.W. Marcoux and D.W. Choi, editors. Pages 3-36.
12. Konrad K, Gunther T, Hanisch C, Herpertz-Dahlmann B. 2004. J. Am. Acad. Child Adolesc. Psychiatry, Differential Effects of Methylphenidate on Attentional Functions in Children With Attention-Deficit/Hyperactivity Disorder. 43: 191-198.
13. Maldonado R, Valverde O, Berrendero F. 2006. Trends Neurosci., "Involvement of the endocannabinoid system in drug addiction". 29 (4): 225-232.
14. Nisoli E, Carruba MO. 2001. Obes Rev (1)., An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with novel mechanism of action. (1): 127-139.
15. Taflinski T, Chojnacka J. 2001. Am. J. Psychiartry, Sibutramine-associated psychotic episode. 157: 2057-2058.
16. Vander Stelt M, Veldhuis WB, Bär PR, Veldinkl GA, Vliegenthart JFG, Nicolay K. 2001. The Journal of Neuroscience, Neuroprotection by 9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicit.
17. Vidal C, Quandte S. 2006. The Drug Monit, Identification of a sibutramine-metabolite in patient urine after intake of a "pure herbal" Chinese slimming product. 28: 690-692.
18. Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ. 2002. J. Atten. Disord. Mechanism of action of methylphenidate: insights from PET imaging studies. Suppl. 1: S31-S43.
19. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL. 2005. J Pharmacol. Exp. Ther., Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. 313 (2): 848-854.
20. WHO Regional Publications. 1998. Guidelines for the Appropriate Use of Herbal Medicines. WHO Regional Office for the Western Pacific.
21. WHO Regional Publications. 2004. WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems. WHO Geneva.
22. Yeun YP, Lai CK, Poon WT, Ng SW, Alber, Chan YW, Tony WL, Mak. 2007. Hong Kong Med. J. 13, Adulteration of over-the counter slimming products with pharmaceutical analogues-an emerging threat. 13: 216-220.
23. Zollman C, Vickers A. 1999. Br. Med. J. ABC of complementary medicine: what is complementary medicine? 319: 693-696.